Our Antimicrobial is underrated. I’m super keen on Btx1801, after having several email conversations with Mark Blaskovich at UQ. See his bio here.
https://researchers.uq.edu.au/researcher/1614
Btx1801 disrupts the biofilm of gram positive bacteria, meaning that resistance is not able to be developed. See article below
https://www.biospace.com/article/btx-1801-kills-superbugs-without-resistance-world-first-study/
Development of antimicrobials is never going to be easy, but the upside is enormous. The phase 2b study is just one example of its use - if Blaskovich/Botanix can prove this works without long-term resistance it will be a global groundbreaking product(s).
All my own opinion, dyor etc.
BOT - Anything but charting, page-7821
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.005(1.79%) |
Mkt cap ! $433.1M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.5¢ | 27.5¢ | $954.6K | 3.406M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 641411 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 249809 | 2 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
28.0¢ |
Change
-0.005 ( 1.78 %) |
||||
| Open | High | Low | Volume | ||
| 28.0¢ | 29.0¢ | 27.5¢ | 1489291 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| BOT (ASX) Chart |